Regional Tolvaptan Registry

Trial Profile

Regional Tolvaptan Registry

Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Heart failure; Hyponatraemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 31 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 15 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top